Jobs IRLDecoding DemocracyA Warmer WorldI've Always Wondered ...

Loading...

0:00
0% played
Stories Tagged as

Pharmaceutical companies

Valeant's story: a cautionary tale

by Dan Gorenstein
Mar 21, 2016
The company's CEO stepped down on Monday
Howard Schiller, then interim CEO of Valeant Pharmaceuticals International, Inc., listens during a hearing of the House Oversight and Government Reform Committee on Capitol Hill February 4, 2016 in Washington, DC. 
BRENDAN SMIALOWSKI/AFP/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

FDA takes step to improve generic drug competition

by Dan Gorenstein
Mar 15, 2016
We'd pay a lot more if it wasn’t for generics, which amount to as much as 85% of what we take.
Joe Raedle/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Valeant swears off aggressive drug pricing strategy

by Dan Gorenstein
Mar 15, 2016
Valeant and a handful other firms may ditch a model that's come under fire.
Valeant and a handful other firms may ditch a model that's come under fire.
Image via Life Science Association of Manitoba/YouTube
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Bad packaging means $3b in drugs will be wasted this year

by Dan Gorenstein
Mar 1, 2016
A new report suggests drug makers are profiting from the waste.
A new report suggests drug makers are profiting from the waste.
Peter Macdiarmid/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Why rare-disease treatments can be big business

by Annie Baxter
Jan 11, 2016
Combined, Shire and Baxalta expect 65 percent of total revenue to come from rare disease treatments.
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Drug company's subsidies to patients under review

by Annie Baxter
Oct 15, 2015
Assistance programs are also marketing tools that can raise overall costs.
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE